All In MedTech

Device Trial Radar · NCT07789041

Use of PuraStat Following Aquablation to Determine if There is Change in Hematuria & Probability of Same Day Discharge

PuraStat for Aquablation Day Case (Use of PuraStat Following an Aquablation Procedure)

Last checked: Nov 20, 2026Latest source record: Aug 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

50

Planned (sponsor's estimate)

Start

Aug 12, 2025

Primary completion

Sep 1, 2026

Study completion Dec 12, 2026

Sponsor

Lead sponsor
Endeavor HealthAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
PROCEPT BioRobotics
First posted
Aug 27, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Supportive care
FDA-regulated device
Yes
Who can join
Male only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Randomized, single-blinded investigational study to assess the safety of PuraStat following the Aquablation procedure

Conditions

  • BPH (Benign Prostatic Hyperplasia)
  • BPH With Symptomatic Lower Urinary Tract Symptoms

Interventions

  • PuraStat hydrogel and the syringeDevice

    PuraStat device is FDA-approved for other uses, such as gastrointestinal endoscopy and ENT (ear, nose, throat) procedures. Its use in this study for urology is investigational.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Hematuria grade at 1-3 hours postop in the PACUTime frame: 1 to 3 hours post procedure

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Glenbrook Hospital- Endeavor Health

    Glenview, Illinois · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.